443.a Fas pathway as an effective target for tolerance induction to pancreatic islet grafts
Prof. Haval Shirwan, United States
443.1 Targeting CD47 improves islet function and survival
Miss Atharva Kale, Australia
443.2 Liver surface can be a promising transplant site for pancreatic islets using a gelatin hydrogel nonwoven fabric combined with ADSCs
Dr. Yukiko Endo, Japan
443.3 Inactive Caspase-1 decreases neutrophil population in allogeneic islet cell transplant model
Dr. Paulomi Mehta, Australia
443.4 Regulatory T cells enhance the engraftment of subcutaneous islet transplantation
Ms. Aya Izuwa, Japan
443.5 USP10 regulates SLC7A11/PFBFB3/TFAP2C axis to inhibit the ferroptosis of allotransplanted islet β cells
Prof. Yi Wang, People's Republic of China
443.6 The epidemiology of hereditary pancreatitis in Australia and its effect on patient of total pancreatectomy with islet auto-transplantation (TPIAT)
Mr. Denghao Wu, Australia
443.7 Human amniotic epithelial cell-islet co-transplantation promotes islet engraftment by suppressing inflammation
Dr. Kaoru Okada, Japan
443.8 Targeting islet inflammation by RIPK3 phosphorylation for type 2 diabetes